Stockreport

Xeris Biopharma (XERS) Is Down 9.3% After XP-8121 Patent Milestone Is Announced – Has The Bull Case Changed? [Yahoo! Finance]

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF In early December 2025, Xeris Biopharma Holdings announced that the USPTO issued a Notice of Allowance for a patent application covering XP-8121, its investigational onc [Read more]